BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 34 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,528,725 | +45.7% | 3,695,000 | +19.4% | 0.00% | – |
| Q2 2023 | $2,422,518 | -11.5% | 3,095,000 | -16.8% | 0.00% | – |
| Q1 2023 | $2,737,920 | +4.8% | 3,720,000 | -36.6% | 0.00% | – |
| Q4 2022 | $2,612,150 | -8.9% | 5,870,000 | +20.5% | 0.00% | – |
| Q3 2022 | $2,867,000 | +8.3% | 4,870,000 | 0.0% | 0.00% | – |
| Q2 2022 | $2,648,000 | +6.8% | 4,870,000 | +12.7% | 0.00% | – |
| Q1 2022 | $2,480,000 | -1.7% | 4,320,000 | +25.4% | 0.00% | – |
| Q4 2021 | $2,522,000 | -46.8% | 3,445,000 | 0.0% | 0.00% | – |
| Q3 2021 | $4,745,000 | +11.5% | 3,445,000 | +32.8% | 0.00% | – |
| Q2 2021 | $4,256,000 | -37.1% | 2,595,000 | -36.8% | 0.00% | – |
| Q1 2021 | $6,770,000 | – | 4,105,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 17,000,000 | $16,407,550 | 4.62% |
| BRAIDWELL LP | 114,338,000 | $109,764,480 | 3.47% |
| Castle Creek Arbitrage, LLC | 10,000,000 | $9,635,000 | 2.27% |
| ARISTEIA CAPITAL, L.L.C. | 67,223,000 | $64,534,080 | 1.74% |
| Graham Capital Management, L.P. | 55,529,000 | $53,481,723 | 1.26% |
| 683 Capital Management, LLC | 14,750,000 | $14,186,550 | 1.10% |
| TFG Asset Management GP Ltd | 5,850,000 | $5,622,500 | 1.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,875,000 | $21,039,375 | 0.87% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,421,000 | $32,084,160 | 0.75% |
| Context Capital Management, LLC | 6,110 | $5,858 | 0.47% |